Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
461.50    0.00 (0.00%)
Bid:
456.00
Ask:
460.00
Spread: 4.00 (0.877%)
Market Cap: £160.29m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Director/PDMR Shareholding

9 Oct 2020 10:59

RNS Number : 6609B
Frontier Developments PLC
09 October 2020
 

9 October 2020

 

Frontier Developments plc

 Option grants/ PDMR Dealings

On 9 October 2020, Frontier Developments plc (AIM: FDEV, 'Frontier' or the 'Company'), a leading developer and publisher of videogames based in Cambridge, UKgranted a total of 28,986 options over Ordinary Shares of 0.5p each in the Company ("Ordinary Shares") under the existing Long Term Incentive Plan ("LTIP") to the Executive Directors (the "Options"). The exercise price of the Options under the LTIP is the nominal value of the Ordinary Shares, being 0.5p each.

Each of the three Executive Directors have been awarded Options over 9,662 Ordinary Shares, to vest in three years subject to achieving certain Total Shareholder Return performance targets over the three year vesting period. The calculation method and performance conditions of these awards are consistent with the awards issued to each Executive Director in 2017, 2018 and 2019.

The Options awarded to the Executive Directors are set out in the table below, together with the total number of Ordinary Shares held under option by each of the Executive Directors under all share option schemes.

 

Name of Director

Position

Number of Options granted on 9 October 2020

Total number of share options held under all schemes following the grants on 9 October 2020

David Braben

Chief Executive Officer

9,662

377,255

Jonathan Watts

Chief Creative Officer

9,662

168,970

Alex Bevis

Chief Financial Officer and Company Secretary

9,662

177,255

 

Enquiries :

Frontier Developments   +44 (0)1223 394 300

David Braben, CEO

Alex Bevis, CFO

Liberum - Nomad and Joint Broker   +44 (0)20 3100 2000

Neil Patel / Cameron Duncan

Jefferies - Joint Broker   +44 (0)20 7029 8000

Max Jones / William Brown

Tulchan Communications   +44 (0)20 7353 4200

Matt Low / Deborah Roney / David Allchurch

 

 

About Frontier Developments plc

Frontier is a leading independent developer and publisher of videogames founded in 1994 by David Braben, co-author of the iconic Elite game. Based in Cambridge, Frontier uses its proprietary COBRA game development technology to create innovative genre-leading games, primarily for personal computers and videogame consoles. As well as self-publishing internally developed games, Frontier also publishes games developed by carefully selected partner studios under its Frontier Foundry games label.

Frontier's LEI number: 213800B9LGPWUAZ9GX18.

www.frontier.co.uk

 

 

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

  

1.  

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: David Braben

2.  

Reason for the notification

a)

Position/status: Chief Executive Officer

b)

Initial notification/Amendment: Initial Notification

3.  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4.  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 0.5p each.

Identification code: GB00BBT32N39

b)

Nature of the transaction: Grant of 9,662 options over ordinary shares of 0.5 pence each with an exercise price of 0.5 pence per share. The Options are due to vest after 3 years (based on TSR performance conditions) and must be exercised within 10 years from the date of award.

c)

Price(s) and volume(s):

Price(s)

Volume(s)

0.5p

9,662

 

d)

Aggregated information:

N/A - Single transaction

 

e)

Date of the transaction: 9 October 2020

f)

Place of the transaction: Outside a trading venue

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Jonathan Watts

2.

Reason for the notification

a)

Position/status: Chief Creative Officer

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 0.5p each.

Identification code: GB00BBT32N39

b)

Nature of the transaction: Grant of 9,662 options over ordinary shares of 0.5 pence each with an exercise price of 0.5 pence per share. The Options are due to vest after 3 years (based on TSR performance conditions) and must be exercised within 10 years from the date of award.

c)

Price(s) and volume(s):

Price(s)

Volume(s)

0.5p

9,662

 

d)

Aggregated information:

N/A - Single transaction

 

e)

Date of the transaction: 9 October 2020

f)

Place of the transaction: Outside a trading venue

1.  

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Alex Bevis

2.  

Reason for the notification

a)

Position/status: CFO and Company Secretary

b)

Initial notification/Amendment: Initial Notification

3.  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4.  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 0.5p each.

Identification code: GB00BBT32N39

b)

Nature of the transaction: Grant of 9,662 options over ordinary shares of 0.5 pence each with an exercise price of 0.5 pence per share. The Options are due to vest after 3 years (based on TSR performance conditions) and must be exercised within 10 years from the date of award.

c)

Price(s) and volume(s):

Price(s)

Volume(s)

0.5p

9,662

 

d)

Aggregated information:

N/A - Single transaction

 

e)

Date of the transaction: 9 October 2020

f)

Place of the transaction: Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKCBPCBDKOKK
Date   Source Headline
1st Jun 202612:05 pmRNSEBT Share Purchase
28th May 20262:30 pmRNS-RPlanet Zoo 2 Announced
22nd May 202611:26 amRNS-RWarhammer 40,000: Chaos Gate – Deathwatch Revealed
22nd May 20269:16 amRNSHolding(s) in Company
19th May 20265:47 pmRNSHolding(s) in Company
18th May 202610:48 amRNSEBT Share Purchase
12th May 20267:00 amRNSTrading Update - FY26 Revenue & Profit Upgraded
23rd Apr 20267:00 amRNSCompletion of Share Buyback Programme
23rd Apr 20267:00 amRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 202611:05 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.